The 10 most recent market catalysts affecting $DH, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Nov 17, 2026
Corporate Catalyst
Neutral
Impact 55
Definitive Healthcare Announces Early-Adopter Findings for AI-Powered Growth Intelligence Platform
Definitive Healthcare disclosed that its AI-powered growth intelligence platform, launched to early adopters in August 2026, has seen over 570 analyses conducted. The positive init…
Nov 6, 2026
Corporate Catalyst
Bearish
Impact 85
Definitive Healthcare Reports Third Quarter 2026 Financial Results
Definitive Healthcare's Q3 2026 results show a 9% year-over-year revenue decrease and a persistent net loss, albeit a smaller one than the prior year. While the net loss improved, …
Nov 5, 2026
Corporate Catalyst
Bullish
Impact 65
Definitive Healthcare Announces Executive Appointments to Bolster AI-powered Initiatives
Definitive Healthcare announced the appointment of Rebecca Marani as Chief Product Officer and Srinivas Attipalli as SVP, Head of AI and Data. This move is a clear strategic initia…
Oct 9, 2026
Corporate Catalyst
Neutral
Impact 55
DarkHorse Files Prospectus For Offering 3.497M Class A Ordinary Shares On Behalf Of Selling Shareholders
DarkHorse has filed a prospectus on Form S-3 to register 3,497,000 Class A ordinary shares for resale by certain selling shareholders. This is a secondary offering, meaning the com…
Oct 6, 2026
Energy/Commodity
Neutral
Impact 65
DarkHorse's Pennyrile Holdings Signs New 50 MW Power Contract; Amunt Not Disclosed
This contract signifies a positive operational milestone for DarkHorse's Pennyrile Holdings, indicating potential revenue growth and increased asset utilization. The undisclosed am…
Sep 2, 2026
Corporate Catalyst
Bullish
Impact 85
Definitive Healthcare shares are trading higher after the company confirmed the receipt of going-private proposal from Advent International. The company also announced the appointment of Clay Ritchey as its CEO.
This headline is a significant corporate catalyst for Definitive Healthcare (DH) as a going-private proposal typically involves a substantial premium over the current market price,…
Sep 2, 2026
Corporate Catalyst
Neutral
Impact 75
Definitive Healthcare Appoints Clay Ritchey CEO, Effective Sept. 8, Succeeding Kevin Coop
Definitive Healthcare announced a change in its top leadership, with Clay Ritchey replacing Kevin Coop as CEO and joining the Board of Directors, effective September 8, 2026. This …
Aug 10, 2026
Corporate Catalyst
Bullish
Impact 75
Definitive Healthcare shares are trading higher after the company reported better-than-expected Q2 adjusted EPS results and raised its FY26 adjusted EPS guidance.
This headline is a significant corporate catalyst for Definitive Healthcare (DH), as better-than-expected earnings and raised guidance directly impact investor confidence and valua…
Aug 10, 2026
Corporate Catalyst
Neutral
Impact 75
Definitive Healthcare Sees Q3 Adj EPS $0.04-$0.05 vs $0.04 Est; Sees Sales $54.000M-$55.000M vs $55.542M Est
Definitive Healthcare announced its Q3 2023 financial guidance, with adjusted EPS projected to be $0.04-$0.05, which is at or slightly above the analyst estimate of $0.04. However,…
Aug 10, 2026
Corporate Catalyst
Bearish
Impact 75
Definitive Healthcare Q2 Adj. EPS $0.05 Beats $0.04 Estimate, Sales $55.195M Miss $55.476M Estimate
Definitive Healthcare's Q2 earnings report shows a mixed performance. While adjusted EPS beat estimates, the sales miss and year-over-year declines in both EPS and sales are concer…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.